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The purpose of the study was to examine how clinicians are identifying, evaluating, and 
utilizing mHealth apps as treatment adjuncts with their clients who have a substance use 
disorder. A sample of 93 participants (20 males, 72 females, and 1 not listed) completed 
measures of demographics and inquiries about their use and evaluation of mHealth apps 
in their practices. Clinicians who work at mental health centers and private practicing 
clinicians were recruited. The majority of the sample (71%) reported that they had not 
utilized mHealth apps with their clients who have a substance use disorder diagnosis. 
Participants who have attended trainings regarding mHealth apps and participants who 
have had client inquiries about mHealth apps were more likely to recommend them to 
their clients. On average, clinicians who utilized mHealth apps only slightly to 
moderately educated clients regarding benefits, drawbacks, and protective measures of 
using mHealth apps. Age was a significant positive predictor for participants educating 
their clients about the benefits and drawbacks of using mHealth apps, whereas years of 
practice was a negative predictor for clinicians educating their clients about the benefits 
and drawbacks of using mHealth apps. Participants primarily recommended mHealth 
apps designed to help users lower stress and assist with restful sleep. Evaluation of 




Chapter 1: Introduction 
Substance Abuse Disorders and Treatment 
 Substance abuse or dependence continues to be a frequently reported occurrence 
in mental health settings (Zhang & Ho, 2016). These reports continue to increase and are 
made by a diverse population, affecting a wide variety of cultures and age groups. This is 
a pertinent problem, as substance abuse disorders (SUDs) cause individuals to become 
more vulnerable to developing other mental health disorders, leading to new obstacles 
and challenges in their lives (Zhang & Ho, 2016). Substance use also contributes to 
morbidity and mortality among youth and young adults, with significant consequences 
including criminality, sexually transmitted diseases, academic failure, and violence 
(Kazemi et al., 2017). The prevalence rate of substance abuse among young adults was 
22%, as reported in a 2014 national survey of drug use and health (Kazemi et al., 2017). 
Even though reports of substance abuse continue to increase, most individuals 
with substance abuse disorders as a primary diagnosis do not seek help (Zhang & Ho, 
2016). In comparison to other mental health disorders, SUDs have the lowest treatment 
rates, despite having the highest burden in terms of morbidity and mortality (Zhang & 
Ho, 2016). Common components of effective treatment include support, structure, and 
goal direction (Kazemi et al., 2017). Effective treatment appears to be characterized by 
counselor-client cohesion and support, moderate structure, and goal-directedness oriented 
toward achieving clients’ personal milestones and objectives. McKowen et al. (2017) 
discussed evidence that the individuals who seek treatment for substance abuse have high 
rates of attrition from treatment. This could lead to learned helplessness and loss of 
motivation for individuals who are attempting to maintain their recovery but struggling 
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with relapse (Wang et al., 2017). With relapse continuing to be a common obstacle for 
individuals with SUDs, clinicians and researchers search for new strategies and 
techniques to aid in treatment. 
mHealth Applications 
Mobile health care (mHealth) denotes the use of mobile devices within a health 
care context (Lui et al., 2017). mHealth is a rapidly growing area that relies heavily on 
mobile applications (apps) deployed to cell phones and handheld devices (Price et al., 
2013). mHealth apps are being constructed to play central roles in evidence-based 
therapies (Price et al., 2013). There are currently a variety of mHealth apps available to 
assist individuals with various mental health symptoms and disorders, with a number of 
them aimed to assist individuals with SUDs (Lui et al., 2017). 
 Some mHealth apps such as Headspace can be used independently, without the 
assistance of a mental health professional; whereas others such as Pear reSET-O are 
designed to be used in conjunction with therapy (Prentice & Dobson, 2014). The majority 
of mHealth apps are self-guided, requiring no support and are most used for self-help 
purposes (Schueller &Torous, 2020). Guided or supported mHealth apps are used to 
increase engagement and effectiveness of the digital treatment, or to use components of 
the mHealth apps to supplement traditional care. mHealth apps for interventions have 
been used to help assess clients’ symptoms as well as to deliver direct treatment to 
clients. They are able to track a variety of behaviors, thoughts, and symptoms, which 
could assist treatment interventions (Prentice & Dobson, 2014). Along with monitoring 
and tracking behaviors, mHealth apps include motivational and educational materials and 
support tools to assist individuals (Kazemi et al., 2017). 
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 mHealth apps have been recently booming, partly due to health care costs and the 
limitations of available one-on-one therapy interventions (Berry & Lai, 2014). mHealth 
apps are low cost, portable, programmable, able to record information, easy to use, 
acceptable to both youth and parents, and have a near constant connectivity. mHealth 
apps are useful in providing psychoeducation, identifying resources, and allowing clients 
to self-monitor, and may open up avenues for two-way communication between 
therapists and clients (Berry & Lai, 2014). 
 Smartphone tools are now found in almost every facet of conventional medicine 
(Luxton et al., 2011). In the U.S., 91% of adults use a mobile phone, with over 50% 
owning smartphones (Kazemi et al., 2017). Berry and Lai (2014) noted that youth have 
access to mobile phones, with 78% of adolescents owning a cellular phone. Rates of 
smartphone use are also high within ethnic minority and low-income populations, 
allowing interventions to reach traditionally underserved populations (Lui et al., 2017).  
 There are currently 165,000 mHealth apps (free and paid) that are publicly 
available (Stoyanov et al., 2016). Over 10,000 of those apps are mHealth apps targeting 
mental health, and many patients are exploring them (Torous et al., 2018). In 2012, 19% 
of individuals who owned a smartphone had at least one app designed to promote health 
behavior or health maintenance (Stoyanov et al., 2016). There is currently a growing 
patient, clinical, government, and payer interest in the potential of mHealth technologies 
for clinical care (Torous et al., 2016). Patients are continuing to bring apps into clinical 
visits with hopes that clinicians can help them make an informed decision on whether the 
app is appropriate for their issues (Torous et al.). 
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Whether mHealth leads to better overall health outcomes and reduced disease 
burden is still unknown and there has been limited empirical research on mHealth apps 
(Kazemi et al., 2017; Kumar et al., 2013). Since mental health and behavioral disorders 
are the largest group of mHealth apps for a specific disease state, it is important for 
clinicians to weigh the pros and cons of using them and know how to evaluate them prior 
to recommending them to clients (Torous et al., 2016). 
Benefits of mHealth Applications 
Increased Self-Monitoring 
A key feature of treating mental health disorders is for patients to monitor their 
own mental health (Proudfoot et al., 2010). Self-monitoring has been shown to improve 
patients’ moods and behaviors and enhances their compliance with treatments. Self-
monitoring is especially important for individuals struggling with SUDs. It is important 
for an individual to identify personal characteristics and experiences that are presumed to 
have triggered the onset of a relapse (McKay et al., 2006). This allows the individual to 
reflect on his or her relapse in order to gain insight to better assist his or her recovery in 
the future. It is beneficial for an individual to reflect on the relapse quickly, as there is a 
decay in the accuracy of memories over time. Daily diaries have been found to be useful 
for individuals to gather data on substance use, mood, cognitions, behaviors, and 
experiences. Keeping a daily diary assists individuals in identifying critical patterns 
(McKay et al., 2006). However, noncompliance is common during treatment of mental 
health disorders. One study found that, when using paper and pencil self-monitoring, 
actual patient compliance was 11% compared to a patient-reported compliance of 90% 
(McKay et al., 2006).  
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Mobile phones offer an alternative to paper and pencil self-monitoring (McKay et 
al., 2006). Using mobile phones, users can be prompted to respond, and these prompts 
can be scheduled for key times. For self-monitoring to be effective, it should take place 
regularly and in real time to reduce recall bias and increase accuracy (Proudfoot et al., 
2010). mHealth apps give individuals the freedom to self-manage their own conditions 
(Zhang & Ho, 2016). They can assist individuals with self-reporting symptoms and can 
assist clinicians with understanding how their clients are progressing (Zhang & Ho). 
Luxton et al. (2011) also noted that, with the use of mHealth apps, clients’ symptoms can 
be easily tracked over a long period of time and can be presented in a useful visual 
display to show treatment outcomes. 
A pilot study was conducted that focused on assessing early-stage effectiveness 
and usability of a smartphone-based intervention system that provides a stand-alone, self-
administered intervention option (Dulin et al., 2014). The intervention provided 
numerous features for intervening with ongoing drinking, cravings, connection with 
supportive others, managing life problems, high-risk location altering, and activity 
scheduling. In the study, 28 participants ranging from ages 22 to 45 used the app for six 
weeks. Participants stated that the app was useful in highlighting alcohol use patterns. 
They noted that tools such as managing alcohol craving, self-monitoring consumption, 
and identifying triggers to drink were particularly helpful. Drinks per day diminished by 
52% by week six of the study (Dulin et al., 2014). 
Increased Homework Compliance  
mHealth apps have the potential to increase homework compliance when used as 
an adjunct to traditional therapy (Lui et al., 2017). Homework adherence closely 
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correlates with overall treatment response, but adherence can be challenging (Price et al., 
2013). Completing homework activities via a mobile app offers multiple methods to 
promote adherence and the collection of real-time data through a prompt for assessment 
may provide helpful feedback (Price et al., 2013). Aguilera and Muñoz (2011) used text-
messaging to assist with increasing homework adherence, improving self-awareness, and 
helping track patient progress. Text-messages consisting of themes of a cognitive 
behavioral therapy intervention were sent out to participants. These themes included 
thought tracking, tracking of pleasant activities, tracking of positive and negative 
contacts, and tracking of physical well-being. Participants responded at a rate of 65% to 
text messages and reported an overall positive experience (Aguilera & Muñoz, 2011). 
Zhang and Ho (2016) noted that text messaging helps individuals maintain their sobriety 
and individuals have a better prognosis when these interventions are implemented early. 
There is increased user autonomy when clients track their symptoms and consistently 
complete homework, which helps shift treatment responsibility from clinician to clients 
(Prentice & Dobson, 2014). 
Increased Transfer of Skills  
    The majority of individuals who seek treatment for substance abuse do not 
maintain continuous abstinence. A study that conducted a multi-site comparison of three 
outpatient treatments for alcoholism found that 40% of the participants reported both 
heavy drinking and recurrent problems within six months after treatment, and another 
19% reported either heavy drinking or recurrent problems at that point (McKay et al., 
2006). Other studies that conducted follow-up research found that 25 to 50% of 
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participants moved back and forth between periods of abstinence and heavy drinking and 
drug use (McKay et al., 2006).  
    mHealth apps may help to enhance the transfer of skills learned in therapy to real 
world settings, by prompting individuals to engage in health protective behavior in the 
environment outside of the clinic (Depp et al., 2011). Apps can include virtual coaches 
that provide real-time audio and visual instruction while patients practice skills (Luxton 
et al., 2011). mHealth apps can also help patients gradually step-down from care and 
provide patients with continued access to interventions after treatment has ended (Depp et 
al., 2011). The accessibility of mHealth apps is useful in addiction because timing is 
critical to preventing a relapse and providers do not typically offer ongoing support after 
treatment has been completed (McTavish et al., 2012). Lindhiem et al. (2015) did a meta-
analysis on the effects of mobile technology on treatment outcome for psychotherapy and 
other behavioral interventions. They looked at 26 articles examining 25 clinical trials and 
found that mobile technology use was associated with superior treatment outcome across 
all study designs and control conditions. Patients who received mobile technology either 
to supplement treatment or substitute for direct contact with a clinician experienced better 
treatment outcome than patients who did not receive any form of mobile technology. 
These findings remained stable among different age groups, diagnoses, study designs, 
and the form of mobile technology used (Lindhiem et al., 2015).  
   According to Quanbeck et al. (2014), there are four systems that operate on mobile 
phones that assist with treating alcohol-use disorders. First, text-messaging monitoring 
and reminder systems are used to keep track of alcohol use and associated symptoms via 
text messages. They are used as a surveillance tool and not as an intervention. Second, 
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text-messaging interventions systems help provide targeted interventions outside of the 
office. One system developed a message-based intervention that, twice a day, delivered 
personalized supportive text messages to patients with alcohol use disorders and 
comorbid depression for three months (Quanbeck et al., 2014). Third, comprehensive 
recovery management systems consist of a variety of tools and services that utilize the 
capabilities characteristic of such mobile devices, including broadband Internet 
connection, interactive multimedia applications, text messages, global positioning system 
(GPS) location awareness, and social networking. Many of these resources can be 
tailored to the specific needs and preferences of the individual user. Lastly, game-based 
systems engage clients using gaming-based neuropsychological interventions in addition 
to treatment. They are used to improve certain cognitive functions, specifically those 
associated with frontal lobe-related impairment. Mobile delivery of a game-based 
neuropsychological intervention may help improve certain aspects of cognitive 
functioning among alcohol-dependent patients, but research in this area is still in 
developmental stages (Quanbeck et al., 2014). 
Examples of Previously Studied mHealth Apps 
   A mHealth app called A-CHESS was studied to determine its effectiveness for 
preventing relapse to heavy drinking for those leaving active alcohol dependence 
treatment (McTavish et al., 2012). It was designed to improve competence, social 
relatedness, and motivation. Participants used A-CHESS heavily and sustained their use 
over time. Among the participants, 94% used the app the first week after leaving 
treatment and at week 16 almost 80% continued to use the app (McTavish et al., 2012). 
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However, the authors noted that further investigation is needed to determine if sustained 
use of A-CHESS prevents relapse or improves treatment outcomes.  
   Rizvi et al. (2011) developed and tested the feasibility of the app DBT Coach 
among individuals with borderline personality disorder and SUDs. Among the 
participants, 22 individuals enrolled in DBT treatment programs. They received the app 
for 10 to 14 days and were instructed to use it as needed. The application first assessed 
the clients’ ratings of emotional intensity and urges to use drugs on a 0 (low) to 10 (high) 
scale; then the clients were asked to identify the emotion that they were experiencing. 
After that, they were asked if they were willing to work on changing their emotion. If 
they were, they were then directed to specific coaching in the use of opposite action 
(OA). If they were not willing, several screens helped the users evaluate the pros and 
cons of changing the emotion. They were instructed to call a therapist if they still did not 
want to change their emotion. Finally, users were again instructed to rate their emotional 
intensity when they were done using the application. Participants used it on average 15 
times and gave high ratings of helpfulness and usability. Results indicated that both 
emotion intensity and urges to use substances significantly decreased within each 
coaching session (Rizvi et al., 2011). 
   Patients have been shown to be positive about the idea of conceptualizing mobile 
phones as a mental health tool (Proudfoot et al., 2010). However, the acceptance is 
conditional upon a number of key features such as whether the program is simple and 
straightforward to use and whether its security and privacy could be guaranteed, 
especially for information sent to the mobile phone. Text message reminders are 
considered useful, as long as they are not intrusive. Feedback graphs are also deemed 
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important. Proudfoot et al. (2016) identified that individuals experiencing mental health 
symptoms indicated that they would be willing to use a mobile phone program more 
often and for longer durations of time, compared to those who were not experiencing 
symptoms. The individuals in the former group were also more likely to want to receive 
text messaging reminders to track their moods and behaviors. Both groups stated that 
they would like feedback on monitoring and to receive self-help suggestions from the app 
(Proudfoot et al., 2010). 
    In all, mHealth interventions have shown promise as a viable resource in the 
prevention, treatment, and aftercare of substance use. Effective use of mHealth apps has 
the potential to increase access to evidence-based care, better inform consumers of care, 
and more actively engage them in treatment (Kazemi et al., 2017; Price et al., 2013). The 
apps can also enhance care after formal treatment has concluded, hopefully cutting down 
on the rates of clients having to re-establish services (Price et al., 2013). Challenges exist, 
however, for mHealth apps directed towards treating substance use, including cost, 
understating which features of the apps account for the seen effects, and keeping up with 
technological advances (Quanbeck et al., 2014). Additionally, while mHealth apps have 
shown promise to improve treatment accessibility and outcomes, a number of drawbacks 
of mHealth apps are also of concern. 
Drawbacks of mHealth Applications 
Limited Scientific Evidence 
While mHealth apps have the potential to be effective, the majority of the apps 
available to the public lack scientific evidence about their efficacy (Donker et al., 2013). 
The efficacy or effectiveness of mobile apps continues to be studied, but there is 
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insufficient empirical support for any one particular app to be considered evidence-based 
(Lui et al., 2017). Due to the small number of studies on any one particular app and the 
small sample sizes included in these studies, current findings should be interpreted with 
caution, until replication studies are conducted (Donker et al., 2013). 
Currently, little or no quality control regulations exist to ensure health apps are 
user-friendly, accurate in content, evidence-based, or efficacious (Boudreaux et al., 
2014). Many apps fail to incorporate evidence-based practices, health behavior theory, or 
clinical expertise (Shen et al., 2015). For the most part, apps are unregulated, which could 
lead to individuals being exposed to apps with incorrect or poor-quality information 
(Weaver et al., 2013). Many apps in the marketplace are of low quality and some are 
even unsafe (Subhi et al., 2014). A review on substance abuse apps stated that 13.3% of 
the participants who used the apps had increased urges to use substances while engaging 
with the apps (Lui et al., 2017). One app that was supposed to help individuals with 
bipolar disorder stated that the disorder was contagious and encouraged the use of alcohol 
to help with manic symptoms (Lui et al., 2017).  
A study on addiction recovery apps found that only 6 of the 52 apps that were 
researched were developed by individuals who had clinical experience or used academic 
or clinical advisors in the development of their apps (Shen et al., 2015). Weaver et al. 
(2013) reviewed 384 alcohol-related smartphone apps. They identified that 50% of the 
apps were for entertainment purposes, 39% were blood alcohol concentration (BAC) 
apps, and 11% were health promotion and/or stop drinking-related apps. The majority of 
the alcohol-related apps encouraged alcohol consumption amongst users, which could be 
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dangerous for an individual searching for an app to assist him or her with substance abuse 
treatment (Weaver et al., 2013). 
Gajecki et al. (2014) tested two smartphone apps targeting drinking choices on 
party occasions, with the goal of reducing problematic alcohol intake among university 
students. Both of the apps measured real time blood alcohol concentration (eBAC). The 
apps studied did not seem to reduce alcohol consumption among university students. One 
of the apps actually showed an increase in drinking among male drinkers, as they might 
have been using it as a drinking game in which peers competed with one another for a 
higher eBAC (Gajecki et al., 2014). Zhang and Ho (2016) found similar trends, noting 
that some individuals who used apps to track BAC used the apps in an attempt to “break 
their record” by drinking more alcohol than a previous time. Weaver et al. (2013) noted 
that apps developed to calculate BAC tend to overestimate BAC. Apps to assist with 
other substances other than alcohol have also been shown to be problematic. Zhang and 
Ho (2016) identified that most marijuana applications are for entertainment purposes. 
Most of the applications do not provide accurate information about the dangers associated 
with marijuana use (Zhang & Ho, 2016).  
Since few systems have empirical evidence of effectiveness, it is important for the 
public to be educated on the limitations of mHealth apps, in addition to their potential 
benefits (Donker et al., 2013; Quanbeck et al., 2014). While individuals may view 
mHealth apps and self-help books as having similar components, most apps do not 
include information about the author and whether he or she is a credible source (Prentice 
& Dobson, 2014). Additionally, most self-help books include a disclaimer informing 
readers that the material is intended for informational purposes. It is suggested that 
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mHealth apps be used in conjunction with therapy, as independent interventions could be 
conducive to misuse and misinterpretations and could even cause harm to the users 
(Prentice & Dobson, 2014). 
Inadequate Protection of Confidentiality & Privacy  
Confidentiality is another concern when using mHealth apps. Data gathered from 
apps can be accessed by unauthorized individuals through digital theft or physical loss of 
a phone (Lui et al., 2017). Apps may also have inadequate data protections. They may not 
disclose what information is gathered and collected by developers; and personal 
information may be distributed to marketers and advertisers unknowingly (Lui et al., 
2017). Gathering patient information on smartphone devices raises concerns about ethics 
and security, especially for clinicians who are responsible for maintaining their clients’ 
confidentiality (Zhang & Ho, 2016).   
Privacy policies are widely used by online service providers in order to regulate 
the use of personal data they collect (Steinfeld, 2016). Often times, users skip reading the 
privacy policy and are unaware of the way information about them is being treated and 
how they can control the ways in which the information is collected, stored, or shared. It 
was found that when the privacy policy was presented by default, more participants 
tended to read it quite carefully. However, when given the option to sign their agreement 
without reading the policy, most participants skip the policy altogether (Steinfeld, 2016).  
Sunyaev et al. (2015) found that, of the most commonly used mHealth apps, only 
183 (30.5%) had privacy policies. Among those policies, the average length was 1755 
words with a reading grade level of 16. Two thirds of the privacy policies did not 
specifically address the mHealth app itself, and the policies, requiring college-level 
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literacy, did not make information about privacy practices transparent to users (Sunyaev 
et al., 2015). When O’Loughlin et al. (2018) reviewed 116 mHealth apps targeting 
depression to evaluate the transparency of data handling procedures, they found that 4% 
received a transparency score of acceptable, 28% questionable, and 68% unacceptable. 
Among these apps, only 49% had a privacy policy (O’Loughlin et al., 2018). 
mHealth Half-Life 
Another issue concerning mHealth apps is that apps have a half-life, when after a 
certain amount of time, an app may no longer be available for public use (Torous et al., 
2018). This could be problematic if a client is using the app as a primary source of 
support. Along these lines, creators of apps have the liberty to update apps as much or as 
little as they would like, and some creators completely abandon support and development 
of an app (Torous et al., 2018).  
In summary, the vast majority of smartphone apps about substances are not 
evidence-based and are largely for entertainment purposes (Zhang & Ho, 2015). Some 
even appear to promote substance use and the apps that claim to estimate BAC are 
unreliable (Zhang & Ho, 2015). While there are texting-based apps that may have 
beneficial effects, they are insufficient as interventions for SUDs (Quanbeck et al., 2014). 
mHealth apps also need improvement in providing better protection of clients’ 
confidentiality and privacy. 
Evaluating mHealth Applications 
When choosing an mHealth app to assist with treatment, therapists should help 
clients decide if the app is appropriate (Prentice & Dobson, 2014). It is challenging to 
evaluate apps, as there are several broad categories of health care apps that are very 
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different in scope, purpose, and use (Torous et al., 2016). Some apps are simply 
developed to track moods and behaviors, while others assist individuals with learning and 
practicing different therapeutic techniques. mHealth apps vary in effectiveness depending 
on the individual user and should be selected on the basis of individual needs, abilities, 
preferences, and other personal factors (Torous et al., 2018). Torous et al. (2018) found 
that, when selecting apps to use in conjunction with therapy, ratings by clinicians of 
individual features suffer from low interrater reliability; app-store ratings, such as star-
based ratings, also had low correlation with the apps’ clinical utility and usability.  
Due to this poor reliability, it is important for healthcare providers to standardize 
their identification, evaluation, and selection of health-related apps to maximize their 
utility, safety, and impact (Boudreaux et al., 2014). Currently, the American Psychiatric 
Association (APA) has developed an app evaluation framework for clinicians and 
patients to make informed decisions about what apps to use (Torous et al., 2018). There 
are a few other scales offered to help individuals make more informed decisions about 
mHealth apps. There is the Mobile App Rating Scale (MARS) that provides a 
multidimensional, reliable, and flexible app-quality rating scale for researchers, 
developers, and health professionals (Stoyanov et al., 2015). However, an individual must 
be formally trained on how to use this scale prior to use. The creators of the MARS 
developed the uMARS, a simpler tool that can be reliably used by end-users to assess the 
quality of mHealth apps (Stoyanov et al., 2016). The uMARS has excellent internal 
consistency for the full scale and good levels for the subscales (Stoyanov et al., 2016). 
Another tool is called “ASPECTS,” and it helps individuals better evaluate mHealth apps 
by having them evaluate different components of an app (Torous et al., 2016).  
16 
 
There are common themes and elements across the different scales/tools. One of 
the main elements is privacy. To successfully facilitate self-monitoring and self-
management via mobile phones, clinicians should place importance on ensuring that the 
programs are secure and private (Proudfoot et al., 2010). The framework developed by 
the APA asks users to consider safety and privacy first (Torous et al., 2018). Many apps 
lack basic privacy policies and exist outside the scope of federal privacy laws, which 
means that apps can be used to collect the personal mental health data of users, and this 
data can be sold, traded, marketed, and indefinitely stored by app companies (Torous et 
al., 2018). The MARS and uMARS also offer a number of questions on their scales to 
assess for confidentiality and security (Stoyanov et al., 2015). The “S” in “ASPECTS” 
stands for secure and asks the clinician to ensure that security features are present in the 
app so that patient confidentiality is not broken (Torous et al., 2016). It is recommended 
that apps be protected by passphrases, biometric authentication, or other security features. 
The app should encrypt patient data on the device itself to ensure that others cannot easily 
read it if the device is stolen or hacked. Clinicians can educate and counsel patients to 
take protective measures while using apps. It is important for apps to be transparent about 
how they work and how they handle privacy. Clinicians should ensure that the app is in 
line with professional standards, including legal and ethical considerations (Torous et al., 
2016). 
 Efficacy is another element that is evaluated amongst the scales/tools. When 
efficacy is evaluated, it is important to realize that, although many apps appear useful, the 
actual efficacy is still developing (Torous et al., 2018). The MARS attempts to examine 
the information offered by apps to ensure that it is research-based and coming from a 
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reliable source (Stoyanov et al., 2015). It is important for clinicians to seek out apps that 
have clinical evidence and efficacy data, while balancing against potential unintended 
consequences, risks, and harm (Torous et al., 2016). Few apps have empirical research to 
support their use as stand-alone treatments, so a trend in the field has been for the apps to 
serve as adjuncts to in-person therapy (Prentice & Dobson, 2014). 
 Another element that is common among the scales/tools is engagement. 
Engagement represents the growing awareness that many patients do not stick with apps 
and find them difficult to use (Torous et al., 2018). It is important to evaluate whether an 
app is engaging to the user and is aesthetically pleasing to work with on a regular basis 
(Stoyanov et al., 2015). When identifying engaging apps, it is important to find ones that 
are customizable and have flexible features (Torous et al., 2016). 
 The final common element among the scales/tools is functionality (Stoyanov et 
al., 2015). It is important for apps to produce data that the patient and clinician can use to 
make informed decisions about the course of clinical care (Torous et al., 2016). Apps 
should have data that can be shared with the treatment team if that data is meant to help 
guide care and help make treatment decisions (Torous et al., 2018). 
 Overall, it is important for clinicians to understand the limitations of mHealth 
apps and be able to evaluate and recommend apps that are appropriate for treatment 
(Zhang & Ho, 2016). It is recommended that clinicians use validated scales to help them 
evaluate the information quality of existing apps (Zhang & Ho, 2016). Based on the 
existing scales, clinicians should examine the privacy, efficacy, engagement, and function 
of mHealth apps prior to recommending them to clients (Stoyanov et al., 2015; Torous et 




 The purpose of the study was to examine how clinicians are identifying, 
evaluating, and utilizing mHealth apps as treatment adjuncts with their clients who have a 
SUD. The use of mHealth apps amongst individuals with SUDs continues to grow on a 
regular basis, with more and more clients asking their clinicians about various apps 
(Torous et al., 2016). When used effectively, mHealth apps have the potential to enhance 
treatment interventions and help clients monitor their symptoms and increase autonomy 
(Prentice & Dobson, 2014). However, there are important concerns that clinicians should 
be aware of prior to recommending a mHealth app to their clients (Boudreaux et al., 
2014). There are currently a number of scales to assist clinicians in evaluating and 
selecting appropriate mHealth apps (Torous et al., 2018). However, there is limited 
empirical evidence on how prevalent it is for therapists to use mHealth apps as treatment 
adjuncts with their clients and, more importantly, how they identify, evaluate, and use 
them to assist with treatment (Aguilera & Muench, 2012). 
          The main research questions of the study are: 
1. What percentage of the clinicians in the study have utilized mHealth apps as 
treatment adjuncts with their clients who have a SUD diagnosis? 
2. What factors (e.g., client inquiry, training, year of practice) significantly correlate 
with clinician’s utilization (yes/no) of mHealth apps?  
3. In regard to the clinicians who have utilized mHealth apps, how much do they 
educate their clients about the benefits and drawbacks of using mHealth apps, 
review the privacy policies of the apps, and identify empirical evidence to support 
the use of the apps, prior to utilizing them?  
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4. What factors (e.g., age, year of practice, training) predict the clinicians’ behaviors 
described in Question 3? 
5. Do mHealth apps that have elements of evidence-based treatments better assist 
with accomplishing treatment goals, compared to mHealth apps that do not?  
6. Are clinicians more likely to recommend mHealth apps that have elements of 
evidence-based treatments, compared to mHealth apps that do not? 
7. Are clinicians more likely to recommend mHealth apps that are customizable and 
engaging?  
8. What types of apps have been utilized and what are the most recommended ones? 
9. How do the clinicians evaluate the apps prior to utilizing them? 
10. Has there been any change in the clinicians’ use of mHealth apps since the 







Chapter 2: Methods 
Participants 
 Participants included 110 licensed clinicians who treat patients with substance 
abuse disorders in the state of Kentucky. Participants were recruited by email and direct 
phone contact. Clinicians who work at mental health centers as well as private practicing 
clinicians were recruited. Clinicians who work at mental health centers were contacted 
via their program managers and directors, who were first contacted and informed about 
the study and were invited to have their centers participate. The mental health centers 
were identified using the 2020 National Directory of Drug and Alcohol Abuse Treatment 
Facilities, created by the Substance Abuse and Mental Health Services Administration. 
Private practicing clinicians were identified via Psychology Today’s public directory and 
contacted by phone and email. 
            Seventeen participants were removed from the data set due to leaving a majority 
of the responses blank or not being a licensed clinician in the state of Kentucky. 
Therefore, these 17 participants were excluded from data analysis, resulting in a final 
sample size of 93, consisting of 20 males (21.5%), 72 females (77.4%), and 1 not listed 
(1.1%). The gender ratio of the sample was largely consistent with that of the US 
therapists population (24.7% male therapists and 70.4% female therapists), based on 
Zippia’s (an employment website for job listings) 2020 demographics (Zippia, 2021). 
The mean age of the final sample was 43.47 years (SD = 10.91), with the median age 
being 43 years. The majority of the sample self-identified as Caucasian (n = 85; 91.4%; 
see Table 1) and reported that they were college graduates with a Master’s degree (n = 




Table 1. Ethnicity Information of the Total Sample (N = 93) 
 
Ethnicity Number Selecting Percent 
 





























   
 
Table 2. Education Information of the Total Sample (N = 93) 
 




















The participants were sampled across Kentucky, with the majority of the sample 
practicing in Warren (n = 19; 20.4%), Jefferson (n = 8; 8.6%), and Fayette (n = 7; 7.5%) 
county. The mean year of practice of the final sample was 10.51 (SD = 8.53), with the 
median year of practice being 22 years. The three most frequently listed licenses were 
Licensed Professional Clinical Counselor (LPCC) (n = 24; 25.8%), Licensed Clinical 
Social Worker (LCSW) (n = 19; 20.4%), and Licensed Professional Counselor Associate 
(LPCA) (n = 10; 10.8%). The top three populations participants worked with consisted 
of: adult mental health outpatient/adult dual-diagnosis outpatient/adult substance abuse 
outpatient (n = 14; 15.1%); adult mental health outpatient (n = 8; 8.6%); and adult and 
22 
 
child mental health outpatient/adult and child dual-diagnosis outpatient/adult and child 
substance abuse outpatient (n = 7; 7.5%). 
 Measures 
The participants were asked to complete a 30-item questionnaire (see Appendix 
A). The questionnaire was developed for this study to obtain information about how 
clinicians who work with clients who have SUDs evaluate and utilize mHealth apps in 
their practice. The questionnaire consisted of eight demographic questions that covered 
information about participants’ age, gender, ethnicity, county of practice, education level, 
type of licensure, years of practice, and client population served. The other 22 questions 
inquired about participants’ evaluation and use of mHealth apps in their practice, for 
example, if clinicians were utilizing mHealth apps in their practice (yes/no), which 
mHealth apps they were recommending to clients (short-answer question), how they 
learned about the mHealth apps they were recommending (multiple choice), their 
understanding of the apps’ privacy policies (Likert scale), how they evaluated mHealth 
apps (short-answer question), how much they educated their clients about the pros and 
cons as well as the protective measures of using mHealth apps (Likert scales), how useful 
the mHealth apps have been in assisting with the completion of treatment goals (Likert 
scale), how likely they would be to recommend mHealth apps to clients in the future 
(Likert scale), if they have attended a training that focused on the use of mHealth apps in 
treatment (yes/no), and if their use of mHealth apps has changed since the start of the 






Data were collected from December 2020 through May 2021, during the COVID-
19 pandemic. Prior to data collection, Institutional Review Board (IRB) approval of the 
study was obtained. The clinicians who indicated willingness to participate during the 
phone communications were sent a follow-up email. The email discussed the purpose of 
the research study and included a link that directed them to the Qualtrics online survey. 
Private practicing clinicians were provided this email directly, and the managers and 
directors at mental health centers were provided the email to forward to their clinicians 
who provide substance abuse treatment. 
Participants completed the online survey via personal computers or mobile 
devices. The Informed Consent Document was embedded in the online survey as the first 
page. The Informed Consent Document provided information about the purpose and 
procedure of the study, the confidentiality policies, and the option to discontinue the 
study at any time. After the participants read the informed consent form, they chose 
whether or not to continue. Continued participation with the online survey implied 
consent.  
          The survey was a 30-item questionnaire. After the questionnaire was completed, 
participants were thanked for their participation and were presented with a debriefing 
statement about the purpose of the study. They also had the option to follow a link to a 
separate Qualtrics survey where they could enter their name and email address to be 
entered into a raffle for one of five $25.00 gift cards to Amazon. After data collection 
was concluded, five of the raffle participants were randomly selected to win the five gift 
cards, which were distributed via emails. 
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Chapter 3: Results 
Factors That Affect Clinicians’ Utilization of mHealth Apps (Yes/No) 
 In regard to Research Question 1, the results showed that the majority of the 
sample (n = 66; 71%) had not utilized mHealth apps with their clients who have a SUD 
diagnosis. To investigate whether age and years of practice influenced clinicians’ 
utilization of mHealth Apps (Question 2), Welch’s unequal variances t-tests were 
conducted to see if there was any significant difference in age or years of practice 
between clinicians who had utilized mHealth apps with their clients (n = 26) and those 
who had not (n = 66). The results showed that the age of participants who had used 
mHealth apps with their clients (M = 45.00, SD = 11.28) was not significantly different 
from the age of those who had not (M= 42.82, SD = 10.77), t(45) = .84, p = .41. The two 
groups did not significantly differ in years of practice either (Ms = 10.62 vs. 10.47; SDs = 
8.77 vs. 8.50), t(45) =.07 , p = .94 
 To examine whether client inquiry (yes/no) and relevant training (yes/no) 
influence clinicians’ utilization of mHealth Apps (Question 2), Chi-Square tests were 
conducted to assess the associations between client inquiry and utilization as well as 
between training and utilization. Clinicians who had client inquiries regarding mHealth 
apps were more likely to utilize mHealth apps than those who had no client inquiry, X2(1, 
N = 87) = 16.86, p < .001. Clinicians who attended a training regarding mHealth apps 
were more likely to utilize mHealth apps than those who had no training, X2(1, N = 88) = 
8.29, p < .004.  
          A Chi-Square test was also conducted to test the association between utilization of 
mHealth apps (yes/no) and whether or not clinicians made changes regarding mHealth 
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apps since the COVID-19 pandemic. The results showed that clinicians who had already 
utilized mHealth apps were more likely to make changes to their use of mHealth apps 
since COVID-19 than those who had not utilized mHealth apps, X2(1, N = 86) = 5.74, p < 
.02. 
Factors That Affect How Clinicians Utilize and Evaluate mHealth Apps 
          Next, analyses were conducted that focused on the clinicians who had utilized 
mHealth apps. For example, how much did they educate their clients about the pros and 
cons of using mHealth apps? How well did they review and understand the privacy 
policies of the apps that they utilized? Did age, year of practice, and training (yes/no) 
impact how they utilize and evaluate mHealth Apps? The results are presented below in 
two sections: Quantitative results (descriptive and inferential) and qualitative results. 
Quantitative Results 
          There were 27 participants who used mHealth apps with their clients who have a 
SUD, consisted of 3 males (11.1%), 23 females (85.2%), and 1 not listed (3.7%). The 
mean age of this sample was 45 years (SD = 11.25), with the median age being 44 years. 
The majority of this sample self-identified as Caucasian (n = 25; 92.6%; see Table 3) and 
reported that they were college graduates with a Master’s degree (n = 22; 81.5%; see 
Table 4).  
Table 3. Ethnicity Information of Clinicians Who Use mHealth Apps (N = 27) 
Ethnicity Number Selecting Percent 
 



















Table 4. Education Information of Clinicians Who Use mHealth Apps (N = 27) 




















        The mean year of practice was 10.62 (SD = 8.77), with the median year of practice 
being 9 years. The top three licenses listed were Licensed Professional Clinical 
Counselor (LPCC) (n = 8; 29.6%), Licensed Professional Counselor Associate (LPCA) 
(n = 7; 25.9%), and Licensed Clinical Social Worker (LCSW) (n = 3; 11.1%). The top 
three populations participants worked with consisted of: adult mental health 
outpatient/adult dual-diagnosis outpatient/adult substance abuse outpatient (n = 4; 
14.8%); adult mental health outpatient/adult dual-diagnosis outpatient (n = 3; 11.1%); 
and adult and child mental health outpatient/adult and child dual-diagnosis 
outpatient/adult and child substance abuse outpatient (n = 3; 11.1%). Thus, the 
demographics of this sample of 27 clinicians were similar to those of the full sample. 
 To address Question 3, descriptive statistics and Pearson Product-Moment 
correlations for the key variables were analyzed (see Tables 5 and 6). As shown by the 
mean values and possible ranges, the clinicians only slightly educated their clients on 
how to take protective measures when using mHealth apps and on the potential 
drawbacks of using the apps. They moderately educated their clients on the benefits of 
using mHealth apps. They slightly reviewed the privacy policies and somewhat 
comprehended the content of the privacy policies. They reported that the mHealth apps 
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moderately assisted with reaching treatment goals and they were moderately likely to 
recommend these apps in the future. Also, as shown in Table 6, significant positive 
correlations were observed among education about protection, education about benefits, 
and education about drawbacks; between review of privacy policy and comprehension of 
privacy policy; between comprehension of privacy policy and review of empirical 
evidence; and between helping meet treatment goals and future recommendation of 
mHealth apps. 
 














Variable M SD Range 
1. Age 45.55 11.75 29-73 
2. Years of Practice 10.55 8.89 1-32 
3. Education about Protection 2.45 1.41 1-5 
4. Education about Benefits 3.27 .88 1-5 
5. Education about Drawbacks 2.59 1.30 1-5 
6. Review of Privacy Policy 3.59 1.37 1-6 
7. Comprehension of Privacy 
Policy 
4.14 1.58 1-6 
8. Empirical Evidence 2.64 1.18 1-5 
9. Treatment Goals 2.68 .99 1-5 
10. Future Recommendation  3.00 1.02 1-5 
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Table 6. Pearson Product-Moment Correlations (Clinicians Who Use mHealth Apps: N 
= 27) 
 
 To answer Question 4, regression analyses were performed to examine whether 
and how age, year of practice, and training (yes/no; dummy-coded) predicted each of the 
following outcome variables: Education about protection, education about benefits, 
education about drawbacks, review of privacy policy, comprehension of privacy policy, 
review of empirical evidence, use of mHealth app data to help meet treatment goals, and 
future recommendation of mHealth apps (see Table 7). The results showed that the 
overall model F statistics were significant for these two outcome variables: Education 
about benefits (F = 5.63, p = .007) and education about drawbacks (F = 5.37, p = .008). 
Specifically, on Education about Benefits, age was a significant positive predictor, B = 
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.06 (SE = .02), p = .003, whereas year of practice was a negative predictor, B = -.07 (SE = 
.02), p = .002. Similarly, on Education about Drawbacks, age was a significant positive 
predictor, B = .08 (SE = .02), p = .005, whereas year of practice was a negative predictor, 
B = -.10 (SE = .03), p = .002. 
 
Table 7. Unstandardized Regression Coefficients Showing the Effects of Age, Year of 
Practice, and Training on Clinicians’ Behaviors Regarding mHealth Apps (Clinicians 
Who Use mHealth Apps: N = 27) 
  Age Year of 
Practice 
Training Adjusted 
R2      
Education about Protection .06 (.03) -.09* (.04) .17 (.63) .16 
Education about Benefits    .06**(.02)   -.07**(.02) .16 (.33) .40 
Education about Drawbacks    .08**(.02)   -.11**(.03) -.05 (.50) .38 
Review of Privacy Policy -.03 (.03) .04 (.04) -.23 (.70) -.11 
Comprehension of Privacy 
Policy 
.02 (.04) -.03 (.05) -.09 (.82) -.14 
Review of Empirical 
Evidence 
.03 (.03) .01 (.04) .51 (.59) -.07 
Use of mHealth Apps to 
Meet Treatment Goals 
.04 (.02) -.04 (.03) .15 (.47) .04 
Future Recommendation of 
mHealth Apps 
.03 (.03) -.02 (.03) .58 (.51) -.06 
 *p<.05; **p<.01; 
 
            Questions 5 through 7 were addressed by conducting Welch’s unequal variances 
t-tests. When comparing apps that have elements of evidence-based treatment (EBT) (n = 
35) with apps that do not (n=5), likelihood of recommendation for them in future was not 
significantly different (Ms = 3.17 vs. 3.00, t (5) = .30, p = .78); these two types of apps 
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did not differ in terms of accomplishing treatment goals either, (Ms = 2.60 vs. 2.60, t (5) 
= .00, p = 1.0).  
When comparing apps that are customizable (n = 22) with apps that are not (n = 
19), likelihood of recommendation for them in future was not significantly different 
(Ms = 3.14 vs. 3.26, t (34) = -.39, p = .70); they are not different in terms of 
accomplishing treatment goals either, (Ms = 2.68 vs. 2.58, t (35) = .36, p = .72).  
Qualitative Results  
         Research Questions 8 to 10 pertain to the qualitative (short answer) questions that 
participants answered on the survey. The analyses focused on what types of apps the 
clinicians have utilized and what are the most recommended ones, how the clinicians 
evaluated the apps prior to utilizing them, and whether and how the clinicians’ use of 
mHealth apps has changed since COVID-19. 
            Recommended mHealth Apps. There were 29 different mHealth apps that 
participants reported using with their clients (see Appendix E). The mHealth apps listed 
have various functions and some serve different purposes from one another. The 
functions of the mHealth apps included: Offering guided meditation, educational 
resources, toolkits with guided therapeutic exercises, journaling functions, mood and 
sobriety tracking, resources for clinicians, messaging with other individuals in recovery, 
and identifying Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) meeting 
times and locations. Three of the apps listed by participants were not listed in the Google 
Play Store or the iOS App Store. The two most recommended mHealth apps among 
clinicians were Calm (n = 9; 33.3%) and Headspace (n = 6; 22.2%). Both of these apps 
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are designed to help users lower stress and assist with restful sleep. Both apps offer a 
variety of guided meditations that can be utilized in various situations. 
 Evaluation of Apps. When asked about how they evaluated the apps prior to 
recommending them to patients, the majority of participants stated that they explored the 
features of the apps themselves (n = 14; 51.9%). Other ways clinicians evaluated apps 
prior to recommending them to patients included: Researching the apps online (n = 2; 
7.4%); reaching out to others who have used the app in order to gain feedback (n = 2; 
7.4%); the company they worked for provided the app (n = 2; 7.4%); examined reviews 
of the app (n = 1; 3.7%); and trusted the app due to being designed by a “reputable 
organization” (n = 1; 3.7%). 
           Future Use of mHealth Apps. Among the participants who use mHealth apps 
with their clients who have a SUD, the majority stated that they would continue to 
recommend apps to their clients in the future due to a variety of reasons, including that 
the apps offer additional support and are readily available (n = 9; 33%); the apps build 
accountability and self-efficacy among clients (n = 2; 7.4%); clients’ learning and 
utilizing mindfulness skills and being able to reflect on the recovery through journaling 
(n = 4; 14.8%); clients able to use the apps as a distraction technique (n = 1; 3.7%); and 
clients being able to track and evaluate their progress with the apps (n = 1; 3.7%). Some 
participants stated that they would recommend mHealth apps depending on the specific 
clients they were treating (n = 2; 7.4%). Other participants stated that they will no longer 
recommend mHealth apps due to clients having poor internet connectivity (n = 1; 3.7%) 
and clients not using the apps, as they prefer more hands-on tools using tangible materials 
(n = 1; 3.7%).  
32 
 
          Changes Since COVID-19. A small portion of the participants stated that their use 
of mHealth apps has changed since the onset of COVID-19 (n = 13; 14%). Some of these 
participants stated that they have started recommending them more to clients due to 12-
step meetings not meeting in person, to clients who were not wanting to come into the 
office to meet face to face, or to clients who might need additional support outside of 
sessions. One participant stated that more clients have mentioned using mHealth apps 
since the onset of COVID-19. Additionally, some participants stated that they are 
personally using mHealth apps for themselves, along with recommending them to 




Chapter 4: Discussion 
The study sought to understand how clinicians evaluate and utilize mHealth apps 
as treatment adjuncts with their clients who have a SUD diagnosis. mHealth apps are 
constructed to play a central role in evidence-based therapies and there are currently a 
variety of them available to assist individuals with various mental health symptoms and 
disorders (Lui et al., 2017; Price et al., 2013). While mHealth interventions have shown 
promise as a viable resource in the prevention, treatment, and aftercare of substance use, 
the vast majority of them are not evidence-based (Kazemi et al., 2017; O’Loughlin et al., 
2018). It is important for clinicians to understand the limitations of mHealth apps and be 
able to evaluate and recommend ones that are appropriate for treatment (Zhang & Ho, 
2016). There is limited empirical evidence on how prevalent it is for therapists to use 
mHealth apps as treatment adjuncts with their clients and how they evaluate and utilize 
them to assist with treatment. The purpose of the study was to conduct a survey to collect 
both quantitative and qualitative data on the topic. 
Factors Impacting Utilization (Yes/No) of mHealth Apps 
 The study sample included 93 mental health clinicians located across Kentucky 
who work with clients with a SUD diagnosis. The majority of the participants were 
female (77.4%), Caucasian (91.4%), and had a master’s degree (86%). The majority of 
the participants (71%) reported that they had not utilized mHealth apps with their clients 
who have a SUD diagnosis. Two factors impacted clinicians’ utilization (yes/no) of 
mHealth apps with their clients. First, clinicians who had client inquiries about mHealth 
apps were more likely to recommend mHealth apps compared to those who received no 
inquiries. Clinicians who attended a training on mHealth apps were also more likely to 
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recommend mHealth apps compared to clinicians who had not attended a training. 
However, age or number of years of practice was not significantly different between 
those who use mHealth apps and those who do not. 
Educating Clients about Utilizing mHealth Apps 
 Clinicians who utilize mHealth apps, on average, only slightly educated their 
clients regarding the drawbacks about mHealth apps and how to take protective measures 
when using them. They also only reported a moderate amount of discussion regarding the 
benefits of using mHealth apps with their clients. This might be due to most U.S. adults 
(over 50%) owning a smartphone and that use of mHealth apps have been recently 
growing (Berry & Lai, 2014; Kazemi et al., 2017). Since owning smartphones and using 
apps are becoming common practice, clinicians may not feel the need to educate their 
clients about the drawbacks of using apps and how to maintain protective measures while 
using them. Receiving limited education regarding drawbacks and protection could leave 
a client vulnerable to having sensitive information unknowingly shared with third-parties.  
           It was found that clinician age was a significant positive predictor for clinicians 
educating their clients about the benefits and drawbacks of using mHealth apps. On the 
other hand, years of practice was a significant negative predictor for clinicians educating 
their clients about the benefits and drawbacks of using mHealth apps. This was an 
interesting finding, as age and years of practice would be assumed to show similar 
impacts on factors given their positive correlation. It could be that, despite being 
positively correlated, age and years of practice are distinct variables. For instance, one 
participant was 59 years old but has only practiced for four years and another participant 
was 73 years old but has only practiced for six years. Older individuals may be more 
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conscientious or patient in general than younger individuals, which could contribute to 
the positive correlation between age and the extent of educating clients about mHealth 
apps. On the other hand, as years of practice increase, clinicians may be more susceptible 
to fatigue or burnout (Dzau et al., 2018), which could be reflected in behaviors such as 
insufficiently educating clients on important information. 
Evaluation and Future Recommendations of mHealth Apps 
App features such as having elements of EBT or not and being customizable or 
not made no significant difference in the likelihood of future recommendation. These 
findings may be due to the lack of training received regarding utilizing mHealth apps. 
Only eight (30.8%) participants who utilize apps with clients reported attending a training 
specifically discussing the use of mHealth apps. If clinicians have not been properly 
trained, they may not understand the importance of evaluating mHealth apps across broad 
categories prior to recommendation.  
Among the 29 different apps that were reported, the two most recommended apps 
were guided meditation apps, designed to help users lower stress and assist with restful 
sleep. It is likely that these apps are recommended because stress and poor sleep relate to 
common factors that impact clients’ relapsing, including increased craving and symptoms 
of anxiety (McKay et al., 2006).  
It was also found that three of the apps listed by participants were not listed in the 
Google Play Store or the iOS App Store. This may be attributed to mHealth apps’ half-
life: After a certain amount of time, an app may no longer be available for public use 
(Torous et al., 2018). This may be a factor that impacts specific mHealth apps gaining 
proper scientific evidence. There are currently very few mHealth apps with proper 
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empirical evidence and the ones that have been evaluated are often not publicly available 
(Schueller & Torous, 2020).  
When examining how clinicians evaluate mHealth apps prior to utilizing them, it 
was found that the majority of participants (51.9%) explored the features of the apps 
themselves. Unfortunately, ratings by clinicians of individual features suffer from low 
interrater reliability (Torous et al., 2018). It is highly recommended that clinicians use a 
standardized scale to identify, evaluate, and select appropriate mHealth apps, to 
maximize their utility, safety, and impact (Boudreaux et al., 2014). None of the 
participants mentioned using a standardized scale when discussing techniques for 
examining mHealth apps prior to recommending them to clients. 
 Finally, a small portion of participants stated that their use of mHealth apps has 
changed since the onset of COVID-19. It was reported that these changes occurred to 
provide additional support during a time when clients had limited in-person resources 
available to them. These reasons fit with the research regarding one of the main purposes 
of mHealth apps, which is for them to assist with barriers that may arise preventing 
clients from receiving face-to-face treatment (Berry & Lai, 2014).  
Clinical Implications and Future Research Directions 
 In light of the study findings, it may be worthwhile to develop improved training 
programs on mHealth apps for clinicians. If clinicians are better trained on the benefits 
and drawbacks of mHealth apps and on how to evaluate the apps with standardized 
scales, they may be able to more effectively work with clients on selecting and using 
mHealth apps to improve safety and treatment outcomes. Due to a large number of 
mHealth apps not having privacy policies and poor transparency among the ones that do 
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have privacy policies, it is important for clinicians to properly educate their clients on 
how to take protective measures. The current study showed that the degree to which 
clinicians reviewed privacy policies had a positive correlation with the extent to which 
clinicians understood the policies, which in turn had a positive correlation with how 
much empirical evidence was identified for the apps. It is recommended that clinicians 
create informed consent documents specifically regarding the use of mHealth apps, to 
review with clients prior to utilization. 
             In terms of future research directions, it will be useful to examine clinicians’ use 
of mHealth apps with a larger and more diverse sample of clinicians from a larger region. 
The current study has a small sample size (n = 93) and consists of participants only from 
Kentucky. It would also be useful to further examine the topic from the clients’ 
perspectives; for example, how clients are identifying, evaluating, and utilizing mHealth 
apps, their perceptions regarding mHealth apps as an adjunct to treatment, and how much 
of an impact mHealth apps have on their treatment. Researchers could also examine what 
specific features of the apps clients believe are the most important, which could be 
informative as clinicians determine which types of apps to recommend in the future. It 
would also be interesting to examine mHealth apps half-life as a part of long-term 
therapy and if clinicians and clients regularly utilize the apps throughout the process.  
In conclusion, the study contributes both quantitative and qualitative data on 
clinicians’ use of mHealth apps in interventions for SUDs. A small percentage of the 
participants (29%) reported that they had utilized mHealth apps with their clients. Client 
inquires and training regarding mHealth apps were the two factors that significantly 
impacted clinicians’ utilization (yes/no) of mHealth apps. Clinicians who utilized 
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mHealth apps only slightly to moderately educated clients regarding benefits, drawbacks, 
and protective measures of using mHealth apps, maybe due to a lack of awareness of the 
importance of such education. Clinicians evaluated mHealth apps primarily by exploring 
the features of the apps themselves, highlighting the need to train clinicians on how to use 
validated standardized scales to examine the privacy, efficacy, engagement, and function 
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Appendix A: mHealth Application Questionnaire 
1. What is your age? 
 
 
2. With which gender identity do you most identify? 
Female Male 
Transgender Female Transgender Male 
Gender Variant/Non-Conforming Not Listed 
Prefer Not to Answer  
 
3. With what racial or ethnic background do you identify? 
American Indian or Alaska Native Two or more races 
Asian White or Caucasian 
Black or African American Other 
Hispanic or Latino Decline to answer 




4. In what state do you practice? 
 
 
5. What is your highest level of education? 
 
 







7. How many years have you been a practicing clinician? 
 
 
8. What client population do you primarily work with? (Check all that apply) 
Adult Mental Health Outpatient Adult Substance Abuse Outpatient 
Adult Dual-Diagnosis Outpatient Adult Mental Health Residential 
Adult Substance Abuse Residential Child/Adolescence Mental Health 
Outpatient 




Child/Adolescence Mental Health 
Residential 




For the purposes of this study, a mobile health (mHealth) phone application (app) 
refers to an application an individual can download to his or her mobile device that 
is designed to assist with various health care needs. Please DO NOT include text 
messaging (e.g. SMS), email (e.g. Outlook), or telecommunication specific (e.g. 
Zoom) apps when completing this survey.   
 
9. Have you ever recommended a mHealth app to a client with a substance use 
disorder for treatment purposes? 
Yes No 
 If no, skip to question 27. 
 
10. Please list the names of the mHealth apps you have recommended to clients with 
substance use disorders.  
App 1  
App 2  
App 3  
 
47 
11. How did you learn about the mHealth apps that you have recommended to clients
with substance use disorders? (Check all that apply)
From a colleague At a conference/training/research article 
From a client From an advertisement 
Came across it while on the internet 
or app store 
Other 
12. In a few sentences, describe how you have evaluated mHealth apps prior to
recommending them to clients with substance use disorders.







14. How much did you review the apps privacy policy prior to recommending the
apps to a client?
App 1 
1 - There 
was no 
policy 
2 - Not at 
all 
3 - Slightly 4 - 
Moderately 








1 - There 
was no 
policy 
2 - Not at 
all 
3 - Slightly 4 - 
Moderately 






1 - There 
was no 
policy 
2 - Not at 
all 
3 - Slightly 4 - 
Moderately 





15. How confident were you that you adequately understood the terms listed in the 
privacy policy? 
App 1 
1 - There 
was no 
policy 




3 - I did not 
understand 
the policy at 
all. 




5 - I mostly 
understood 
the policy. 






1 - There 
was no 
policy 




3 - I did not 
understand 
the policy at 
all. 




5 - I mostly 
understood 
the policy. 






1 - There 
was no 
policy 




3 - I did not 
understand 
the policy at 
all. 




5 - I mostly 
understood 
the policy. 






16. How much did you educate clients on how to take protective measures when
using mHealth apps?
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extensively 
17. How much did you educate clients about the benefits of using mHealth apps prior
to recommending them?
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extensively 
18. How much did you educate clients about the potential drawbacks of using
mHealth apps prior to recommending them?
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extensively 
19. How much empirical evidence did you identify to support the use of the specific
apps you recommended?
App 1 
1 - None 2 - A small 
amount 
3 - A moderate 
amount 
4 - A fair 
amount 
5 - An extensive 
amount 
App 2 
1 - None 2 - A small 
amount 
3 - A moderate 
amount 
4 - A fair 
amount 
5 - An extensive 
amount 
App 3 
1 - None 2 - A small 
amount 
3 - A moderate 
amount 
4 - A fair 
amount 
5 - An extensive 
amount 















22. Did you use the app prior to recommending them to clients to identify how








23. Did you utilize data collected in the app during treatment sessions?
24. Was data collected in the app able to be shared with the treatment team?
25. How well did the apps assist with accomplishing treatment goals?
App 1 
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extremely 
App 2 

















1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extremely 
 
26. How likely are you to recommend these mHealth apps to clients with substance 
use disorders in the future? 
App 1 
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extremely 
 
App 2 
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extremely 
 
App 3 
1 - Not at all 2 - Slightly 3 - Moderately 4 - Quite a bit 5 - Extremely 
 
27. Please briefly explain why you would or would not recommend mHealth apps to 
clients with substance use disorders in the future. 
 
 
28. Has a client with a substance use disorder ever asked you about a mHealth app 
that they have learned about or have been using? 
Yes No 
 
29. Have you ever attended a training that specifically discussed the use of mHealth 





30. Has your use of mHealth apps changed since the COVID-19 pandemic?
Yes No 
If so, please explain how it has changed. 
54 
 









Appendix D: Debriefing Statement 
Thank you for your participation in this experiment. The goal of this study was to 
examine how therapists located in the United States of America are using mHealth phone 
applications (apps) in their practice to treat substance use disorders. It seeks to identify 
how many therapists are using mHealth apps to assist with treatment interventions, what 
types of apps are frequently being recommended, how they are evaluating apps prior to 
recommending them to clients, and whether and how therapists inform their clients of the 
pros and cons of the recommended apps. Your participation is greatly appreciated by the 
researchers involved. 
If you would like to be entered into the raffle to win a $25.00 Amazon gift card, please 





Appendix E: mHealth Apps Listed by Participants 
 
3 Good Things 
7 Cups of Tea 
12 Steps App 
24 hours a day 
AA Big Book 
ACT Coach 
Calm 
Day to Day 
Daylio 





















Note: mHealth apps listed in this study should not be considered an endorsement by the 
author. The author cannot guarantee the efficacy of the apps presented above. 
 
